These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27802290)

  • 61. Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases.
    Albus A; Jördens M; Möller M; Dodel R
    Front Immunol; 2019; 10():2033. PubMed ID: 31507618
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
    Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
    Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.
    Ono K; Noguchi-Shinohara M; Yoshita M; Naiki H; Yamada M
    Exp Neurol; 2007 Feb; 203(2):579-83. PubMed ID: 17011551
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
    Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease.
    Duyckaerts C; Clavaguera F; Potier MC
    Curr Opin Neurol; 2019 Apr; 32(2):266-271. PubMed ID: 30724769
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects.
    Aho L; Parkkinen L; Pirttila T; Alafuzoff I
    Dement Geriatr Cogn Disord; 2008; 25(5):423-32. PubMed ID: 18391488
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia.
    Gold M; Mengel D; Röskam S; Dodel R; Bach JP
    J Neuroinflammation; 2013 Jan; 10():5. PubMed ID: 23317003
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
    Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O
    J Parkinsons Dis; 2016; 6(1):99-108. PubMed ID: 26756745
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuroinflammation is linked to dementia risk in Parkinson's disease.
    Kouli A; Spindler LRB; Fryer TD; Hong YT; Malpetti M; Aigbirhio FI; White SR; Camacho M; O'Brien JT; Williams-Gray CH
    Brain; 2024 Mar; 147(3):923-935. PubMed ID: 37757857
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson's Disease.
    Folke J; Bergholt E; Pakkenberg B; Aznar S; Brudek T
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742998
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Natural IgG antibodies to β amyloid are decreased in patients with Parkinson's disease.
    Paganelli R; Paganelli A; Pawelec G; Di Iorio A
    Immun Ageing; 2023 Mar; 20(1):13. PubMed ID: 36906630
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia.
    Akhtar RS; Xie SX; Brennan L; Pontecorvo MJ; Hurtig HI; Trojanowski JQ; Weintraub D; Siderowf AD
    Mov Disord Clin Pract; 2016; 3(4):367-375. PubMed ID: 27500181
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunotherapeutic Approaches for the Treatment of Neurodegenerative Diseases: Challenges and Outcomes.
    Sushma ; Mondal AC
    CNS Neurol Disord Drug Targets; 2023; 22(3):404-416. PubMed ID: 34963438
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Disturbed sleep in Parkinson's disease: anatomical and pathological correlates.
    Kalaitzakis ME; Gentleman SM; Pearce RK
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):644-53. PubMed ID: 23363035
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia.
    Yang L; Wang H; Liu L; Xie A
    Front Neurosci; 2018; 12():73. PubMed ID: 29515352
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In pursuit of degenerative brain disease diagnosis: Dementia biomarkers detected by DNA aptamer-attached portable graphene biosensor.
    Bodily TA; Ramanathan A; Wei S; Karkisaval A; Bhatt N; Jerez C; Haque MA; Ramil A; Heda P; Wang Y; Kumar S; Leite M; Li T; Zhao J; Lal R
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2311565120. PubMed ID: 37956285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parkinson's Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron.
    Han J; Fan Y; Wu P; Huang Z; Li X; Zhao L; Ji Y; Zhu M
    Front Aging Neurosci; 2021; 13():743754. PubMed ID: 34707492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo.
    Braczynski AK; Sevenich M; Gering I; Kupreichyk T; Agerschou ED; Kronimus Y; Habib P; Stoldt M; Willbold D; Schulz JB; Bach JP; Falkenburger BH; Hoyer W
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.